Abstract:SESSION TITLE: COPD II SESSION TYPE: Original Investigation Poster PRESENTED ON: Saturday, April 16, 2016 at 11:45 AM - 12:45 PM PURPOSE: Recent studies suggest that has been implicated in the pathogenesis of various inflammatory diseases. It is currently unknown, however, whether YKL-40 plays a role in COPD airway remodeling. METHODS: Here, we evaluated IL-17A expression in the lung of patients with COPD and smokers without COPD, as well as in controls. The association between IL-17A expression and airway remodeling was analyzed. In parallel, IL-17A-/- mice and wild-type control animals were exposed to cigarette smoke for 3 months, and airway inflammation and airway remodeling were assessed. The effects of IL-17A on collagen synthesis of primary human lung fibroblasts were also evaluated. RESULTS: Our data showed that IL-17A expression were elevated in the lung of COPD patients as compared to smokers without COPD and non-smokers. IL-17A expression correlated positively with collagen deposition. After exposing wild-type and IL-17A-/- mice to mainstream cigarette smoke (CS) for 3 months, IL-17A expression was increased in mice upon CS exposure. CS-treated IL-17A-/- mice exhibited reduced lung collagen content, smooth muscle area, mucus-producing cells, and inflammatory cell accumulation as compared with wild-type mice. Reduced matrix metalloproteinase-2 activity and expression of transforming growth factor-β1 and vascular endothelial growth factor were observed in CS-treated IL-17A-/- mice. Lung fibroblasts from IL-17A-/- mice showed reduced proliferation, migration, collagen deposition, and α-smooth muscle actin expression in comparison with CS-treated wild-type lung fibroblasts. Stimulation with IL-17A promoted collagen production in lung fibroblasts through ERK- and p38-dependent mechanisms. CONCLUSIONS: we demonstrate that IL-17A is key for the development of CS-induced airway remodeling in COPD. In response to allergen, IL-17A induces the switching of lung fibroblasts to a pro-fibrogenic myofibroblast phenotype. The current data may provide insight into the underlying pathogenesis of COPD, in which IL-17A has an important pathogenic role. CLINICAL IMPLICATIONS: IL-17A play an improtant in airway inflammation and airway remodeling. Thus, therapeutics targeting IL-17A might prove efficacious in the treatment of COPD. DISCLOSURE: The following authors have nothing to disclose: Tianwen Lai, Bao-ping Tian, Chao Zhang, Yue Hu, Luanqing Che, Feng Xu, Songmin Ying, Wen Li, Zhihua Chen, Huahao Shen No Product/Research Disclosure Information

Interleukin-17A Promotes Airway Remodeling in Chronic Obstructive Pulmonary Disease by Activating C-X-C Motif Chemokine Ligand 12 Secreted by Lung Fibroblasts

Il-17a is Elevated in Patients with Copd and Contributes to Airway Remodeling by Acting on Fibroblasts

IL-17A is Elevated in Patients with Chronic Obstructive Pulmonary Disease and Contributes to Airway Remodeling by Acting on Fibroblasts

Epithelium-derived IL17A Promotes Cigarette Smoke-induced Inflammation and Mucus Hyperproduction.

C-EBPβ mediates in cigarette/IL-17A-induced bronchial epithelial-mesenchymal transition in COPD mice

WNT/β-catenin Signaling Regulates Cigarette Smoke-Induced Airway Inflammation Via the PPARδ/p38 Pathway

Upregulation of IL-17A/F from Human Lung Tissue Explants with Cigarette Smoke Exposure: Implications for COPD

Lung Dysfunction in a Mouse Model of Inflammation is Dependent on T-cell-independent IL-13 Expression (54.18)

Cathelicidin induces epithelial-mesenchymal transition to promote airway remodeling in smoking-related chronic obstructive pulmonary disease

Epigenetic Regulation of IL-17-Induced Chemokines in Lung Epithelial Cells.

Anti-Interleukin-17 Antibodies Attenuate Airway Inflammation in Cigarette Smoke-Induced Chronic Obstructive Pulmonary Disease in Mice

Il4 And Il-17a Provide A Th2/Th17-Polarized Inflammatory Milieu In Favor Of Tgf-Beta 1 To Induce Bronchial Epithelial-Mesenchymal Transition (Emt)

LL-37 secreted by epithelium promotes fibroblast collagen production: a potential mechanism of small airway remodeling in chronic obstructive pulmonary disease

Enhanced Airway Inflammation and Decreased Subepithelial Fibrosis in Interleukin 6‐deficient Mice Following Chronic Exposure to Aerosolized Antigen

IL-17A, but Not IL-17F, is Indispensable for Airway Vascular Remodeling Induced by Exaggerated Th17 Cell Responses in Prolonged Ovalbumin-Challenged Mice

Interleukin-20 promotes airway remodeling in asthma

The Changes and Significance of Interleukin-17 in Rat Models of Chronic Obstructive Pulmonary Disease and Asthma

Cigarette Smoke-Induced Lymphoid Neogenesis in COPD Involves IL-17/RANKL Pathway

HDAC2 Suppresses IL17A-Mediated Airway Remodeling in Human and Experimental Modeling of COPD.

Genetic Deletion of IL-17A Reduces Cigarette Smoke-Induced Inflammation and Alveolar Type II Cell Apoptosis.

Interleukin-22 exacerbates airway inflammation induced by short-term exposure to cigarette smoke in mice